Dr. Mark Awad

Dr. Mark Awad, MD, PhD, is a distinguished thoracic medical oncologist and Chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center (MSK), where he leads an exceptional team of lung and thoracic cancer specialists at the David H. Koch Center for Cancer Care. His career in oncology was profoundly influenced by his father's successful treatment for cancer at MSK through a lifesaving clinical trial, inspiring him to pursue a path dedicated to cancer care and research.

Board-certified in medical oncology, Dr. Awad specializes in treating lung cancer and other thoracic cancers, with particular expertise in immunotherapy and cellular therapy approaches. He leads multidisciplinary clinics treating lung cancer, tracheal cancer, and thymic cancers, with both in-person and telemedicine options for patient care.

Dr. Awad's approach to patient care emphasizes comprehensive analysis of radiology scans, pathology, genomics, and immune profiles to recommend the most precise and tailored treatment options. He ensures patients receive care in a warm, compassionate, and inclusive environment where all are welcome, treating each patient as if they were his own family.

A trailblazer in clinical and translational research, Dr. Awad has led the development of multiple novel targeted therapies and immunotherapies for lung cancer. He was pivotal in advancing personalized neoantigen vaccines in combination with chemotherapy and immunotherapy, and his groundbreaking work on mechanisms of resistance to targeted therapies has been published in the New England Journal of Medicine, Cancer Cell, and other prestigious journals.